cyanidin-3-o-beta-glucopyranoside and Diabetic-Retinopathy

cyanidin-3-o-beta-glucopyranoside has been researched along with Diabetic-Retinopathy* in 2 studies

Other Studies

2 other study(ies) available for cyanidin-3-o-beta-glucopyranoside and Diabetic-Retinopathy

ArticleYear
Cyanidin-3-o-glucoside (C3G) inhibits vascular leakage regulated by microglial activation in early diabetic retinopathy and neovascularization in advanced diabetic retinopathy.
    Bioengineered, 2021, Volume: 12, Issue:2

    Topics: Animals; Anthocyanins; Cell Line; Cell Movement; Diabetic Retinopathy; Endothelial Cells; Humans; Inflammation; Mice; Mice, Inbred C57BL; Microglia; Neovascularization, Pathologic; RNA, Messenger

2021
Cyanidin-3-
    Journal of agricultural and food chemistry, 2020, Aug-05, Volume: 68, Issue:31

    Topics: Animals; Anthocyanins; Apoptosis; Cataract; Cyclooxygenase 2; Diabetic Retinopathy; Epithelial Cells; Gene Expression Regulation; Glucose; Humans; Lens, Crystalline; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Signal Transduction

2020